SCINAI IMMUNOTHERAPEUTICS LTD.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-15.0M | $3.1M |
| FY2021 | — | $982.0K | $17.4M |
| FY2022 | — | $-1.8M | $14.1M |
| FY2023 | — | $-4.6M | $4.9M |
| FY2024 | — | $10.0M | $2.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-15.0M | $3.1M |
| FY2021 | — | $982.0K | $17.4M |
| FY2022 | — | $-1.8M | $14.1M |
| FY2023 | — | $-4.6M | $4.9M |
| FY2024 | — | $10.0M | $2.0M |